stockrowAmphastar Pharmaceuticals, Inc. (AMPH) vs Collegium Pharmaceutical, Inc. (COLL)
- Amphastar Pharmaceuticals, Inc. AMPH 28.65 +3.58%
- Collegium Pharmaceutical, Inc. COLL 24.56 −2.38%
Amphastar Pharmaceuticals, Inc. and Collegium Pharmaceutical, Inc. are both Drug Manufacturers Specialty & Generic companies. Amphastar Pharmaceuticals, Inc. is the larger, with a market value of $1.2B against $819.1M — 1.4× the size. Amphastar Pharmaceuticals, Inc. trades at the lower P/E: 12.3× against 20.5×. Collegium Pharmaceutical, Inc. grew revenue faster over the last twelve months: 7.68% against 3.11%. Amphastar Pharmaceuticals, Inc. has the higher net margin (13.3% vs 4.68%) and the higher return on invested capital (6.12% vs 5.63%). Across the 21 metrics below, Amphastar Pharmaceuticals, Inc. leads on 12 and Collegium Pharmaceutical, Inc. on 9.
Valuation
Profitability
| Metric | AMPH | COLL | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 46.81% | 59.05% | 53.51% |
| Operating margin | 18.74% | 15.22% | 0.00% |
| Net margin | 13.27% | 4.68% | (2.45%) |
| Free cash flow margin | 18.64% | 41.25% | 0.00% |
| Return on equity | 12.44% | 13.36% | (0.80%) |
| Return on assets | 5.86% | 2.06% | (1.67%) |
| Return on invested capital | 6.12% | 5.63% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack